实用临床医学
實用臨床醫學
실용림상의학
Practical Clinical Medicine
2014年
4期
71-73
,共3页
子宫全切术%腹腔镜%经阴道%开腹
子宮全切術%腹腔鏡%經陰道%開腹
자궁전절술%복강경%경음도%개복
total hysterectomy%laparoscope%transvaginal%laparotomy
目的:探讨不同子宫全切术的临床疗效和安全性。方法将行子宫全切术的90例患者按随机数字表法分为A组、B组和C组,每组30例。 A组接受腹腔镜下子宫全切术,B组接受经阴道子宫全切术,C组接受传统开腹子宫全切术,比较3组的临床效果。结果 A组肛门排气时间、下床活动时间、住院时间明显低于B、C组(P<0.05),A组住院费用明显高于B、C组(P<0.05)。 A组患者术前及术后3个月雌二醇、卵泡刺激素(ESH)、黄体生成素(LH)及孕酮水平与B组和C组比较差异无统计学意义(均P>0.05)。 A组远期并发症发生率(23.3%)明显低于A组(73.3%)及B组(76.7%)(P<0.05)。结论腹腔镜子宫全切术效果更好,但费用较贵。
目的:探討不同子宮全切術的臨床療效和安全性。方法將行子宮全切術的90例患者按隨機數字錶法分為A組、B組和C組,每組30例。 A組接受腹腔鏡下子宮全切術,B組接受經陰道子宮全切術,C組接受傳統開腹子宮全切術,比較3組的臨床效果。結果 A組肛門排氣時間、下床活動時間、住院時間明顯低于B、C組(P<0.05),A組住院費用明顯高于B、C組(P<0.05)。 A組患者術前及術後3箇月雌二醇、卵泡刺激素(ESH)、黃體生成素(LH)及孕酮水平與B組和C組比較差異無統計學意義(均P>0.05)。 A組遠期併髮癥髮生率(23.3%)明顯低于A組(73.3%)及B組(76.7%)(P<0.05)。結論腹腔鏡子宮全切術效果更好,但費用較貴。
목적:탐토불동자궁전절술적림상료효화안전성。방법장행자궁전절술적90례환자안수궤수자표법분위A조、B조화C조,매조30례。 A조접수복강경하자궁전절술,B조접수경음도자궁전절술,C조접수전통개복자궁전절술,비교3조적림상효과。결과 A조항문배기시간、하상활동시간、주원시간명현저우B、C조(P<0.05),A조주원비용명현고우B、C조(P<0.05)。 A조환자술전급술후3개월자이순、란포자격소(ESH)、황체생성소(LH)급잉동수평여B조화C조비교차이무통계학의의(균P>0.05)。 A조원기병발증발생솔(23.3%)명현저우A조(73.3%)급B조(76.7%)(P<0.05)。결론복강경자궁전절술효과경호,단비용교귀。
Objective To investigate the clinical efficacy and safety of different types of total hysterectomy. Methods Ninety patients were randomly treated with total laparoscopic hysterectomy (group A, n=30), total vaginal hysterectomy (group B,n=30) or total abdominal hysterectomy (group C, n=30). Clinical efficacy was compared among the three groups. Results Compared with group A, anus exhaust time, out-of-bed activity time and hospital stay were significantly prolonged and hospitalization costs were significantly decreased in both group B and group C (P<0.05). In addition, the incidence of long-term complications in group A (23.3%) was significantly lower than that in group B (73.3%) or group C (76.7%)(P<0.05). There were no obvious differences in the levels of estradiol, follicle stimul-ating hormone, luteinizing hormone and progesterone among the three group(P>0.05). Conclusion Total laparoscopic hysterectomy results in better efficacy but higher costs.